Skip to main content
Premium Trial:

Request an Annual Quote

Rana Therapeutics Secures Access to Santaris LNA Technology

Premium

Rana Therapeutics, a developer of gene-activation therapeutics, has inked a deal to use Santaris Pharma’s locked nucleic acid technology to develop drugs against up to 10 proprietary targets.

In exchange, Santaris will receive an upfront payment, as well as target nomination payments, development milestones, and royalties.

Specific terms of the deal were not disclosed.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.